Search
Iratumumab
go.drugbank.com/drugs/DB05550InvestigationalIn phase I/II clinical trials for treatment of CD30+ lymphomas.
TG100-115
go.drugbank.com/drugs/DB05552InvestigationalAn NSAID that inhibits PI-3K gamma and delta.
Synonyms: 3-(2,4-Diamino-6-(3-hydroxyphenyl)pteridin-7-yl)phenol, 6,7-Bis(3-hydroxyphenyl)pteridine-2,4-diamineCategories: Heterocyclic Compounds, 2-Ring, Phosphatidylinositol 3-Kinases, antagonists & inhibitorsBlarcamesine
go.drugbank.com/drugs/DB05592InvestigationalSynonyms: Tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanemethanamine, Anavex 2-73Categories: Heterocyclic Compounds, 1-RingFibroblast growth factor-1
go.drugbank.com/drugs/DB05599InvestigationalCategories: Fibroblast Growth Factor 1Synonyms: Fibroblast growth factor-1MKC-1
go.drugbank.com/drugs/DB05608InvestigationalCategories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingNE-180
go.drugbank.com/drugs/DB05619ExperimentalNE-180 was under investigation in a clinical trial conducted in the European Union.
Synonyms: GlycoPEGylatedâ„¢rHuEPOAVI-4065
go.drugbank.com/drugs/DB05620InvestigationalAVI-4065, a phosphorodiamidate Morpholino oligomer (PMO), is an investigational antisense HCV drug. It was developed by Sarepta Therapeutics, Inc.
OT-551
go.drugbank.com/drugs/DB05650InvestigationalA leading cause of vision loss, AMD affects approximately 10 million Americans. … OT-551 is a novel small molecule that is topically dosed in an eye drop and has the unique ability to penetrate cell membranes and reach both the front and the back of the eye.
Categories: Heterocyclic Compounds, 1-RingPalifosfamide
go.drugbank.com/drugs/DB05668InvestigationalPalifosfamide (ZIO-201) is a proprietary stabilized metabolite of ifosfamide. Ifosfamide has been shown to be effective in high doses in treating testicular cancer, sarcoma and lymphoma.
Categories: Heterocyclic Compounds, 1-RingATL-104
go.drugbank.com/drugs/DB05670InvestigationalATL-104 is a potent mitogen for epithelial cells of the gastrointestinal tract. In animal models, ATL-104 aids regeneration of the gastrointestinal tract after treatment with chemotherapeutic agents.